We investigated whether 6-gingerol affects the maturation and proliferation of
osteoblast-like MG63 cells in vitro. Osteoblast-like MG63 cells were
treated with 6-gingerol under control conditions, and experimental inflammation was
induced by tumor necrosis factor-α (TNF-α). Expression of different osteogenic
markers and cytokines was analyzed by real-time PCR, Western blotting, and
enzyme-linked immunosorbent assay. In addition, alkaline phosphatase (ALP) enzyme
activity and biomineralization as markers for differentiation were measured.
Treatment with 6-gingerol resulted in insignificant effects on the proliferation
rate. 6-Gingerol induced the differentiation of osteoblast-like cells with increased
transcription levels of osteogenic markers, upregulated ALP enzyme activity, and
enhanced mineralized nodule formation. Stimulation with TNF-α led to enhanced
interleukin-6 and nuclear factor-κB expression and downregulated markers of
osteoblastic differentiation. 6-Gingerol reduced the degree of inflammation in
TNF-α-treated MG-63 cells. In conclusion, 6-gingerol stimulated osteoblast
differentiation in normal physiological and inflammatory settings, and therefore,
6-gingerol represents a promising agent for treating osteoporosis or bone
inflammation.